
1. jpn j ophthalmol. 2008 nov-dec;52(6):463-467. doi: 10.1007/s10384-008-0589-8.
epub 2008 dec 17.

quantitative pcr detection genomic dna epstein-barr virus ocular
fluids patients uveitis.

yamamoto s(1), sugita s(1), sugamoto y(1), shimizu n(2), morio t(3), mochizuki
m(4).

author information: 
(1)department ophthalmology & visual science, tokyo medical dental
university, tokyo, japan.
(2)department virology, medical research institute, tokyo medical dental
university, tokyo, japan.
(3)center cell therapy, tokyo medical dental university, tokyo, japan.
(4)department ophthalmology & visual science, tokyo medical dental
university, tokyo, japan. m.manabu.oph@tmd.ac.jp.

purpose: measure genomic dna epstein-barr virus (ebv) ocular
fluids analyze clinical relevance ebv uveitis.
methods: intraocular fluids (30 aqueous humor 30 vitreous fluid samples) were
taken 55 patients uveitis informed consent obtained. samples 
were assayed ebv dna using qualitative multiplex polymerase chain reaction
(pcr) quantitative real-time pcr. antibodies ebv examined using a
complement fixation test.
results: ebv dna detected 17 60 samples (28%) 16 55 patients
(29%) using multiplex pcr. however, three 17 samples showed
significantly high copy numbers ebv dna real-time pcr. ebv dna not
detected serum patients. ebv-specific antibodies positive in
the serum patients, vitreous fluid. vitreous anti-ebv
antibodies positive patients displaying genomic dna ebv the
vitreous samples.
conclusions: ebv dna detected qualitative pcr ocular fluids many
uveitis patients, small proportion patients showed high viral loads
on quantitative real-time pcr, indicating replication virus takes
place patients.

doi: 10.1007/s10384-008-0589-8 
pmid: 19089567  [indexed medline]

